Method of suppressing appetite with vanadium complexes
US5688784A · kind A · utility
7Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Nov 18, 1997 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided vanadium compositions for use in the treatment of hypertension, obesity and diabetes, in particular improved oral compositions comprising oxovanadium (IV) chelates of monoprotic, bidentate oxygen, oxygen and oxygen, nitrogen coordinating ligands especially kojic acid and maltol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.